Network analytics and machine learning for predictive risk modelling of cardiovascular disease in patients with type 2 diabetes

A high proportion of older adults with type 2 diabetes (T2D) often develop cardiovascular diseases (CVD). Diagnosis and regular monitoring of their multimorbidity is clinically and economically resource intensive. The interconnectedness of their health data and disease progression pathways can potentially reveal the multimorbidity risk if carefully analysed by data mining and network analysis techniques. This study proposed a risk prediction model utilising administrative data that uses network-based features and machine learning techniques to assess the risk of CVD in T2D patients. For this, two cohorts (i.e., patients with both T2D and CVD and patients with only T2D) were identified from an administrative dataset collected from the private healthcare funds based in Australia. Two baseline disease networks were generated from two study cohorts. A final disease network was then generated from two baseline disease networks through normalisation. This study extracted some social network-based features (i.e., the prevalence of comorbidities, transition patterns and clustering membership) from the final disease network and some demographic characteristics directly from the dataset. These risk factors were then used to develop six machine learning prediction models to assess the risk of CVD in patients with T2D. The classifiers accuracy ranged from 79% to 88% shows the potential of the networkand machine learningbased risk prediction model utilising administrative data. The proposed risk prediction model could be useful for medical practice as well as stakeholders to develop health management programs for patients at a high risk of developing chronic diseases.

Automated summary

The study proposed a risk prediction model utilizing administrative data to assess the risk of cardiovascular diseases in type 2 diabetes patients, achieving classifiers accuracy ranging from 79% to 88%. The model shows potential for medical practice and stakeholders to develop health management programs for high-risk patients developing chronic diseases.